Clinical trials query results
From Health Canada
- Medical condition:
- DEPRESSION
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN (COMP360)
- Protocol title:
- A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A SINGLE ADMINISTRATION OF COMP360 IN PARTICIPANTS WITH TREATMENT-RESISTANT DEPRESSION
- Sponsor name:
- COMPASS PATHFINDER LIMITED
- Date of no objection letter:
- 2023-06-22
- Control number:
- 275503
- Trial status:
- ONGOING
- Date study started:
- 2023-09-13